These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 19795464)
1. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor. Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464 [TBL] [Abstract][Full Text] [Related]
2. Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells. Greupink R; Bakker HI; van Goor H; de Borst MH; Beljaars L; Poelstra K Pharm Res; 2006 Aug; 23(8):1827-34. PubMed ID: 16850269 [TBL] [Abstract][Full Text] [Related]
3. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768 [TBL] [Abstract][Full Text] [Related]
5. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems. Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158 [TBL] [Abstract][Full Text] [Related]
6. A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier. Prakash J; de Jong E; Post E; Gouw AS; Beljaars L; Poelstra K J Control Release; 2010 Jul; 145(2):91-101. PubMed ID: 20362019 [TBL] [Abstract][Full Text] [Related]
7. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity. Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor. Zavorka ME; Connelly CM; Grosely R; MacDonald RG Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692 [TBL] [Abstract][Full Text] [Related]
9. Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo. Zheng K; Li R; Zhou X; Hu P; Zhang Y; Huang Y; Chen Z; Huang M Int J Nanomedicine; 2015; 10():5327-42. PubMed ID: 26346331 [TBL] [Abstract][Full Text] [Related]
10. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development. Hébert E Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663 [TBL] [Abstract][Full Text] [Related]
11. Selective induction of apoptosis in MCF7 cancer-cell by targeted liposomes functionalised with mannose-6-phosphate. Minnelli C; Cianfruglia L; Laudadio E; Galeazzi R; Pisani M; Crucianelli E; Bizzaro D; Armeni T; Mobbili G J Drug Target; 2018 Mar; 26(3):242-251. PubMed ID: 28795851 [TBL] [Abstract][Full Text] [Related]
12. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Lee JS; Weiss J; Martin JL; Scott CD Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555 [TBL] [Abstract][Full Text] [Related]
15. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581 [TBL] [Abstract][Full Text] [Related]
16. Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA. Haorah J; MacDonald RG; Stoner JA; Donohue TM Biochem Pharmacol; 2003 Feb; 65(4):637-48. PubMed ID: 12566093 [TBL] [Abstract][Full Text] [Related]
17. Mannose-6-phosphate/insulin-like growth factor-II receptor in human melanoma cells: effect of ligands and antibodies on the receptor expression. Laube F Anticancer Res; 2009 Apr; 29(4):1383-8. PubMed ID: 19414391 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells. Zhang J; Zhang QS; Chen XM; Tian GY Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489 [TBL] [Abstract][Full Text] [Related]
19. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer. Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703 [TBL] [Abstract][Full Text] [Related]
20. Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cells. Caixeiro NJ; Martin JL; Scott CD Int J Cancer; 2013 Dec; 133(11):2542-50. PubMed ID: 23686499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]